公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Predicted Quantum Topological Hall Effect and Noncoplanar Antiferromagnetism in K0.5RhO2 | Zhou J.; Liang Q.-F.; Weng H.; Chen Y.B.; Yao S.-H.; Chen Y.-F.; Dong J.; Guo G.-Y. | Physical Review Letters | 41 | 43 | |
2021 | Radiofrequency ablation of benign thyroid nodules: Recommendations from the Asian conference on tumor ablation task force | Ha E.J.; Baek J.H.; Che Y.; Chou Y.-H.; Fukunari N.; Kim J.-H.; Lin W.-C.; My L.T.; Na D.G.; Quek L.H.H.; MING-HSUN WU ; Yamakado K.; Zhou J. | Ultrasonography | 32 | 28 | |
2016 | Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis | JIA-HORNG KAO ; Tung S.-Y.; Lee Y.; Thongsawat S.; Tanwandee T.; Sheen I.-S.; Wu J.J.; Li H.; Brennan B.J.; Zhou J.; Le Pogam S.; Najera I.; Thommes J.A.; Hill G. | Journal of Gastroenterology and Hepatology (Australia) | 10 | 7 | |
2020 | Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial | CHIH-HSIN YANG ; Camidge D.R.; Yang C.-T.; Zhou J.; Guo R.; Chiu C.-H.; Chang G.-C.; Shiah H.-S.; Chen Y.; Wang C.-C.; Berz D.; Su W.-C.; Yang N.; Wang Z.; Fang J.; Chen J.; Nikolinakos P.; Lu Y.; Pan H.; Maniam A.; Bazhenova L.; Shirai K.; Jahanzeb M.; Willis M.; Masood N.; Chowhan N.; Hsia T.-C.; Jian H.; Lu S. | Journal of Thoracic Oncology | 87 | 75 | |
2020 | Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019) | Ren L.; Zhu D.; Benson A.B.; III, Nordlinger B.; Koehne C.-H.; Delaney C.P.; Kerr D.; Lenz H.-J.; Fan J.; Wang J.; Gu J.; Li J.; Shen L.; Tsarkov P.; Tejpar S.; Zheng S.; Zhang S.; Gruenberger T.; Qin X.; Wang X.; Zhang Z.; Poston G.J.; Xu J.; Zhou A.; Parvaiz A.; Zhu A.; Eng C.; Lau C.-W.; Song C.; Tang C.-N.; Lynch C.; Wan D.; Loyer E.; Aucejo F.; Wang F.; Chang G.J.; Chen G.; Yang G.-Z.; Choi G.-S.; Wieshmann H.; Tulina I.; Oh J.H.; Ngu J.C.; Wang J.-Y.; Zhou J.; Jin J.; JIN-TUNG LIANG ; Wang J.; Kwak J.-M.; Okuda J.; Lee K.-Y.; Ding K.; Kuo L.-J.; Ito M.; Ohue M.; Zeng M.; Valente M.; Miyoshi N.; Bianchi P.P.; Lan P.; Xu R.; Cai S.; Kim S.-H.; Wang S.; Zeng S.; Ng S.S.; Krishnamurthi S.; Fenwick S.; Akiyoshi T.; Liu T.; Maughan T.; Konishi T.; Law W.L.; Zhang W.; Sun W.; Chen W.T.-L.; Wang Y.; Wang Y.; Yuan Y.; Sun Y.; Hou Y.; You Y.N.; Lee Y.-S.; Yao Y.; Liu Y.; Kinugasa Y.; Zhang Z.; Yan Z.; Pan Z.; Xu Z.; Zhou Z.; the SINCE (Shanghai International Consensus Expert Group on Colorectal Liver Metastases) Group | European Journal of Surgical Oncology | 26 | 17 | |
2016 | Surgery for intermediate and advanced hepatocellular carcinoma: A consensus report from the 5th Asia-pacific primary liver cancer expert meeting (apple 2014) | MING-CHIH HO ; Hasegawa K.; Chen X.-P.; Nagano H.; Lee Y.-J.; Chau G.-Y.; Zhou J.; Wang C.-C.; Choi Y.R.; Poon R.T.-P.; Kokudo N. | Liver Cancer | 69 | 69 | |
2020 | Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial | Wu Y.-L.; Cheng Y.; Zhou J.; Lu S.; Zhang Y.; Zhao J.; Kim D.-W.; Soo R.A.; Kim S.-W.; Pan H.; Chen Y.-M.; Chian C.-F.; Liu X.; Tan D.S.W.; Bruns R.; Straub J.; Johne A.; Scheele J.; Park K.; CHIH-HSIN YANG ; Liu Z.; Chen X.; Wang M.; Yu S.; Zhang H.; Fang J.; Li W.; Yang C.-H.; Chang G.-C.; Hsia T.-C.; Yang C.-T.; Wang C.-C.; Cho B.C.; Lee K.H.; Kim Y.-C.; An H.J.; Woo I.S.; Cho J.Y.; Shin S.W.; Lee J.-S.; Kim J.-H.; Yoo S.S.; Kato T.; Shinagawa N.; Tan S.W.D.; Ngo L.S.-M.; Ratnavelu K.; Ahmad A.R.; Liam C.K.; de Marinis F.; Tassone P.; Molla A.I.; Calles Blanco A.; Lazaro Quintela M.E.; Felip Font E.; Dingemans A.-M.; Bui L. | The Lancet Respiratory Medicine | 161 | 128 |